Hint mode is switched on Switch off
For swift navigation between sections

EMZOR PHARMA Bonds, 10% 20jan2026, NGN (1) (10.00% EPF JAN 2026, NGEPF2026S15)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard

PDF download

Choose all Reset all
Download Cancel

Domestic bonds, Secured

Status
Matured
Amount
13,729,000,000 NGN
Placement
***
Redemption (put/call option)
*** (-)
ACI
Country of risk
Nigeria
Current coupon
-
Price
Yield / Duration
Calculate in two clicks! yield, duration and other parameters
Calculate in two clicks! yield, duration and other parameters
Calculator What is a calculator?
  • Placement amount
    13,729,000,000 NGN
  • Outstanding amount
    13,729,000,000 NGN
  • Face value
    1,000 NGN
  • ISIN
    NGEPF2026S15
  • CFI
    DBFSFR

Try in 7-days Trial access

Free for company representative

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
  • Evaluate advanced analytical tools
Sign up

Why Cbonds?

  • 24 Years of Market Leadership
  • Trusted by clients across 90 countries for decades of reliable service
  • Used by Financial Professionals & Fintech central banks, asset managers, fintech innovators
  • Convenient platform for private investors for informed investment decisions

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Files

Prospectus

Authorization required
It is only possible to download bond prospectuses for paid Premium subscription access

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
No more than two exchanges can be selected for comparison at the same time
Bond is not traded; the issue is redeemed
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription

Issue information

Profile
From a humble beginning as a retail chemist’s shop in January 1977 to one of Nigeria’s most respected, indigenous multi-billion naira pharmaceutical companies today, we have come a long way. Today, we manufacture over 140 high-quality ...
From a humble beginning as a retail chemist’s shop in January 1977 to one of Nigeria’s most respected, indigenous multi-billion naira pharmaceutical companies today, we have come a long way. Today, we manufacture over 140 high-quality pharmaceutical products and medical consumables including analgesics, vitamins, haematinics, anti-malarials, anti-tussives, antibiotics, anti-helmintics, anti-histamine, antacid, and cardio-protective drugs. We are a wholly owned, indigenous Nigerian company and we choose to remain that way for the betterment of our country and its people. Our choice to manufacture drugs locally has the dual aim of providing affordable, value-rich healthcare to our people as well as building employment and manufacturing capabilities in the region.
Show more Hide
Research report by Cbonds-PRAAMS Save
Authorization required
Report download is available only paid Premium subscription access
  • Issuer
    Go to the issuer page
    EMZOR PHARMA
  • Full borrower / issuer name
    EMZOR PHARMA
  • Sector
    Corporate
  • Industry
    Miscellaneous Healthcare: Products and Services
  • SPV / Issuer
    Emzor Pharma Funding SPV PLC
Volume
  • Placement amount
    13,729,000,000 NGN
  • Outstanding amount
    13,729,000,000 NGN
Face value
  • Face value
    1,000 NGN
  • Outstanding face value
    *** NGN
  • Increment
    *** NGN
Listing
  • Listing

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Business Day Convention
    Modified Following Business Day
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***

Cash flow

Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Order book
    *** - ***
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • Use of proceeds
    Refinance
    Working Capital
    Capital Expenditures
  • Use of proceeds description
    The net proceeds of the bonds from Emzor Pharma Funding SPV Plc will be utilised as follows:
    1. Refinancing of existing short-term debt and overdraft: NGN 400,000,000 (2.91%);
    2. Working Capital Usage: NGN 682,452,771 (4.97%);
    3. Expansion of Existing Operations: NGN 4,850,000,000 (35.33%);
    4. New Greenfield Development: NGN 7,500,000,000 (54.63%);
    5. Transaction Expenses on the Bonds: NGN 296,547,229 (2.16%)
Participants
  • Bookrunner
    ***

Conversion and exchange

  • Conversion terms
    ***

Similar issues

Identifiers

  • State registration number
    10.00% EPF JAN 2026
  • ISIN
    NGEPF2026S15
  • Cbonds ID
    1047467
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • CFI
    DBFSFR
  • Type of security by CBR
    ***

Bond classification

  • Secured
  • Registered
  • Coupon bonds
  • Non-complex financial instruments (MiFID)
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

Registration is required to get access.